Evidence map›Paper›PMID 41753301›Full record

ArticleJournal of clinical medicine2026

Association of IMP3 and CD10 Expression with Clinicopathological Features and Outcomes in Phyllodes Tumors: A Retrospective Single-Center Study.

Hülya Odabaşı Bükün, Erdem Çubukçu, Adem Deligönül, Ahmet Bilgehan Şahin, Alper Coşkun, Gül Akın, Çağla Karaoğlu, Ali Aktaş, İlkay Gönül, Mine Özşen and 2 more

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Hülya Odabaşı BükünDepartment of Medical Oncology, Uludag University, 16100 Bursa, Türkiye.ORCID 0009-0000-5432-4981
Erdem ÇubukçuDepartment of Medical Oncology, Uludag University, 16100 Bursa, Türkiye.
Adem DeligönülDepartment of Medical Oncology, Uludag University, 16100 Bursa, Türkiye.ORCID 0009-0001-3931-0191
Ahmet Bilgehan ŞahinDepartment of Medical Oncology, Uludag University, 16100 Bursa, Türkiye.ORCID 0000-0002-7846-0870
Alper CoşkunDepartment of Medical Oncology, Uludag University, 16100 Bursa, Türkiye.ORCID 0000-0003-2444-6587
Gül AkınDepartment of Medical Oncology, Uludag University, 16100 Bursa, Türkiye.
Çağla KaraoğluDepartment of Medical Oncology, Uludag University, 16100 Bursa, Türkiye.ORCID 0000-0002-1737-4469
Ali AktaşDepartment of Medical Oncology, Uludag University, 16100 Bursa, Türkiye.ORCID 0000-0003-2794-6915
İlkay GönülDepartment of Internal Medicine, Uludag University, 16100 Bursa, Türkiye.ORCID 0009-0007-9180-749X
Mine ÖzşenDepartment of Pathology, Uludag University, 16100 Bursa, Türkiye.ORCID 0000-0002-5771-7649
Seyit Ali Volkan PolatkanDepartment of General Surgery, Uludag University, 16100 Bursa, Türkiye.
Türkkan EvrenselDepartment of Medical Oncology, Uludag University, 16100 Bursa, Türkiye.ORCID 0000-0002-9732-5340

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

breast neoplasmCD10immunohistochemistryIMP3phyllodes tumorprognosisrisk stratificationstromal biomarkerssurvival

Identifiers

PMID41753301
PMCPMC12942521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.